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Thrombocytopenia   occurs in pregnancy like 
in the non-pregnant state and may actually 
predate conception in some instances. It can be 
due to immune thrombocytopaenic   purpura 
1which is a diagnosis of exclusion .  This may be 
unknown pre-pregnancy because  of  
spontaneous remission; it may be secondary to 
an underlying disorder such as an autoimmune 
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ABSTRACT
Thrombocytopenia   occurs in pregnancy like in the non-pregnant state and can be due to immune 
thrombocytopaenic   purpura (ITP). The hyperoestrogenic state of pregnancy has been identified as 
a precipitating factor. This is a case report of a thirty year old Nigerian lady, who at a gestational age 
of 26 weeks developed ITP as a near miss mortality. Although, most literatures reported that the 
perinatal outcome is usually favourable in this condition, we report a case managed in our facility 
that had intrauterine death and non- remission until delivery; despite corticosteroid therapy and 
transfusion of eleven (11) units of blood. This report is relevant in a developing world where a rare 
condition almost caused a maternal death in spite of the high maternal mortality rates from other 
conditions. Baseline full blood count is advocated at booking to identify and monitor rare 
haematological disorders like this in pregnancy. 
(Immune thrombocytopaenic purpura, Nigeria, perinatal mortality, pregnancy)
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2-5disease . The hormonal changes of pregnancy 
may precipitate a recurrence in a woman at risk 
and others may present for the first time in 
pregnancy. Other causes in pregnancy may 
range from such pregnancy specific conditions 
such as Pre- eclampsia to non-specific isolated 
1-conditions like gestational thrombocytopaenia
6. Immune thrombocytopenia (ITP) occurs in 
0.1-1per 1,000 pregnancies, and accounts for 
5% of cases of pregnancy-associated 
7thrombocytopenia . Despite its rarity compared 
to gestational thrombocytopenia (vide infra), 
ITP is the most common cause of isolated 
thrombocytopenia in the second and third 
3,7,8trimesters . 
We present a case report of immune 
thrombocytopaenic  purpura in pregnancy with 
an adverse perinatal outcome.
CASE SUMMARY
Mrs. A.F, a thirty year old secundigravida 
presented at a gestational age of 26 weeks with a 
week history of bleeding gum, epistaxis, black 
patches on the chest and forearm. There was 
history of haematuria and melena stool which 
necessitated her seeking medical advice. There 
was no history of generalized bone pain, not a 
known sickle cell disease and no similar history 
in the first pregnancy. 
 There was a preceding history of a low grade 
fever, catarrh and other flu- like symptoms; 
however, there was no haemoptysis, vaginal 
bleeding or trauma. She had episodes of 
childhood epistaxis that did not require any 
medical treatment.
There was no family history of similar 
symptoms. Her last pregnancy was not 
adversely eventful and she had a vaginal 
delivery of a live female infant at term.  Index 
pregnancy was also uneventful until the onset of 
the presenting complaints. The patient was a 
civil servant with a Higher National Diploma 
certificate. She was the only wife of her 
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husband. She did not smoke cigarettes and 
neither took alcohol.
She was acutely ill-looking, afebrile and pale but 
not jaundiced, with blood coated tongue, 
generalized ecchymosis and petechiae. There 
was no significant lymphadenopathy. There was 
tachypnoea and dyspnoea at rest, though the 
lung fields were clear.  Her blood pressure was 
100/60mmHg. She had tachycardia, the first and 
second heart sounds were heard with no 
murmurs and a tender hepatomegaly was 
demonstrable. There was no splenomegaly.
The uterus was enlarged to a size of gestational 
age of 28 weeks, the lie was longitudinal and 
fetus was presenting cephalic. The fetal heart 
rate was 168 beats per minute. There was no 
vaginal bleeding and the cervix was closed.
She was admitted in the emergency ward. Her 
packed cell volume at admission was 37%, 
9 9WBC = 6.9 x10 /L and platelet count = 9x 10 /L. 
There were no abnormal or blasts cells on the 
peripheral blood film. Coagulation screening 
tests such as Prothrombin time (PT) and 
Activated partial thromboplastin time (APTT) 
were normal. An assessment of Immune 
thrombocytopaenic purpura to exclude sepsis 
was made.
The liver and the renal ultrasound scans were 
normal. Similarly, the obstetric ultrasound scan 
at admission was normal with a single live 
intrauterine fetus at 27 weeks with adequate 
liquor volume.
She was then reviewed with the haematologist 
and  joint management with the obstetric unit 
included the transfusion of  one unit of fresh 
whole blood  daily, oral prednisolone 20mg 
thrice daily, intravenous cefuroxime 750mg 
eight hourly and haematinics.
The symptoms continued on admission despite 
the steroid therapy and the serial PCV check 
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dropped to 19%. This necessitated blood 
transfusion and she had a total of 11 pints of 
blood. Calcium gluconate was given after every 
4 pints of blood. 
A repeat obstetric scan at gestational age of 32 
weeks confirmed an intrauterine fetal death 
after the patient complained of cessation of fetal 
movements. She had cervical ripening and 
induction of labour with misoprostol. She was 
delivered vaginally of a female stillborn that 
weighed 2kg . Subsequently, her general 
condition improved, the bleeding stopped and 
her packed cell volume and platelet count 
improved significantly .She was later 
discharged home on prednisolone and 
haematinics. At follow up visit, her packed cell 
volume ( PCV) was 37% and platelet count was 
9
130 x10 /l. Prednisolone was then tailed off 
gradually until it was completely discontinued. 
Her last clinic visit to the hematologist was on 
th
the 8  June 2011 and her general clinical 
condition was satisfactory.
DISCUSSION
Immune Thrombocytopenia (ITP) formerly 
known as Idiopathic thrombocytopenic purpura 
is a common haematologic disorder caused by 
evolution of auto- antibodies against platelets. 
It is mostly due to IgG antibodies(92%), others 
such as IgM and IgA antibodies are also 
implicated in few cases. This antibodies coat 
the platelets leading to their accelerated and 
1,2,3,6
premature destruction in the spleen . These 
platelet associated IgG are considered to be 
1,2,6
autoantibodies , that also cross the placenta to 
cause fetal thrombocytopenia in 9-15% of 
2-6 
cases .In addition to the increased destruction 
of platelets, there is also suppression of 
megakaryopoiesis in severely affected patients.
ITP account for 5% of cases of pregnancy 
associated thrombocytopenia and 1.5% of 
babies of affected mothers develop intracranial 
haemorrhage during labour with consequent 
prenatal mortality in about 20% of cases; 
intrauterine fetal death is also said to occur 
2,3,5
occasionally .   
9
ITP is defined as a platelet count of <100 x 10 /L 
 1
(100,000/µL) , Mrs. A.F. was admitted with a 
9
platelet count of 9 x 10 /L. which was far less 
9
than the 100 x 10 /L
The precipitating factors of ITP include, 
helicobacter pylori, SLE, Lymphoma, Chronic 
lymphocytic leukaemia , drugs, viruses such as 
1,5
HIV  and hyperestrogenaemia  of pregnancy is 
2
also suggested as a cause . The prior viral 
infection and pregnancy were the probable 
precipitants in this patient.  
1,2 
Presentation is common in young women  and 
common signs and symptoms as include 
epistaxis, haematuria, bleeding gums and 
bleeding from puncture site; petechiae 
1-3
haemorrhages and echymosis .Mrs. A.F was 
thirty years old with the above presentation in 
the third trimester. In pregnancy, plateletet count 
is lower ,more especially in the third trimester as 
a result of haemodilution and increased platelet 
2
activation and clearance . 
A history of prior thrombocytopenia and an 
underlying autoimmune disease make the 
3
diagnosis more likely .Although, there was no 
history suggestive of autoimmune disease in 
Mrs A.F there is a possibility of prior 
thrombocytopenia that presented as childhood 
epistaxis which resolved spontaneously and was 
never linked to ITP. Probably, its recurrence was 
due to the hyperestrogenaemia of pregnancy and 
the prior flu-like symptoms flared up an 
autoimmune response as well. Sometimes, it 
may be asymptomatic and only detected on 
2
routine antenatal baseline investigations .  
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Significant thrombocytopenia in the first 
trimester, with a declining platelet count  as 
gestation progresses is most consistent with 
3
ITP . Index patient was unbooked, so platelet 
count could not be assessed earlier than the time 
of presentation. More so, platelet count is not a 
routine investigation in our centre and except 
for a high index of suspicion, it would not have 
been done without the presenting signs and 
symptoms. 
Laboratory investigations should include a 
peripheral blood film which should be normal 
except  fo r  the  presence  of  severe  
 1, 3, 5
thrombocytopenia (<50,000/µL) . The   
peripheral film in the index patient showed 
9
PCV of 19% and platelet count of 9 x 10 /L 
indicat ing severe thrombocytopenia.  
Ultimately the best diagnostic study is the 
1
assessment of patient response to ITP therapy . 
Index patient had only significant response to 
steroid therapy after delivery; suggesting the 
role of pregnancy in her presentation. 
ITP patients should be jointly managed with the 
3, 7-9 
haematologist as was done for this patient. 
Index patient presented with bleeding episodes, 
9
PCV of 19% and platelet count of 9 x 10 /L; this 
necessitated the transfusion of eleven pints of 
blood. She also had first line drugs in the 
management of ITP particularly prednisolone 
which impairs autoantibody production and 
1-6
inhibit phagocytosis of opsonised platelet . 
Where available, Intravenous immunoglobulin 
(IVlg) is also used as a first line drug for those 
with severe thrombocytopenia, it is however 
1-3,6
very expensive and scarce . Erythromycin has 
also been used with good response because of 
10
its immunomodulatory effect . Splenectomy as 
an option of management is indicated in patient 
who fail to respond adequately to corticosteroid 
or IVlg within 2-3 weeks; those in whom 
massive doses are needed and those with 
2,3,6
frequent recurrences .
A limitation in the management of this patient 
was the inability to screen for autoimmune 
disease and demonstration of platelet auto- 
antibodies because of non-availability of 
facilities. The absence of blast cells on the 
peripheral blood film and a normal WBC count 
excluded a leukaemia. Anti – human globulin 
test (Coomb's test) was negative and this 
excluded Evan's test. We were able to investigate 
the patient within our limited resources and 
arrive at a reasonable conclusion since ITP is a 
diagnosis of exclusion and the peripheral blood 
film and FBC excluded other causes. This 
supports the current recommendation of 
baseline investigations in the management of 
11,12
primary immune thrombocytopenia .
Irrespective of the route of delivery, platelet 
count of >50,000/µL is needed for delivery and 
for those undergoing epidural or spinal 
anaesthesia, a platelet count of > 80,000/µL is 
3,5
required . 
Vaginal delivery is advised and caesarean 
section should only be for obstetric indication; 
and any procedure in labour that poses 
additional bleeding risk in the fetus like fetal 
scalp electrode, fetal blood sampling and 
4,5,9,11
instrumental deliveries should be avoided .
While on treatment with prednisolone,the 
patient noticed sudden reduction of fetal 
movement with an ultrasound scan confirming 
intrauterine fetal death (IUFD).IUFD, though 
rare might have been due to fetal haemorrhage 
caused by transplacental transfer of platelet 
associated IgG autoantibodies as a result of the 
severe maternal  thrombocytopenia. A 
postmortem could have suggested the likely 
cause of the intrauterine fetal demise but this is 
not a routinely favoured request in our 
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environment for cultural reasons. Patient 
eventually had a vaginal   delivery of a 
macerated stillborn.  Patient was continued on 
prednisolone and peripheral film on follow up 
visit showed PCV of 37% and platelet count of 
9
130 x 10 /L. 
 ITP is an uncommon but important cause of 
thrombocytopenia in pregnancy.  It is generally 
not associated with major morbidity if properly 
managed.  Low dose corticosteroids and IV Igs 
are the mainstay of treatment. 
ITP is an uncommon disorder in our 
environment but caused significant maternal 
morbidity and perinatal mortality in this patient. 
In addition, she was a case of near miss 
mortality. We recommend baseline FBC at 
booking in our environment so as to identify 
such uncommon disorders that may contribute 
to maternal deaths. This becomes crucial when 
one considers the high maternal mortality rates 
in our environment; therefore there should be 
prompt identification of rare but fatal 
conditions like ITP during antenatal care. 
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